4.6 Article

Clinical features and biomarkers of semantic variant primary progressive aphasia with MAPT mutation

Journal

ALZHEIMERS RESEARCH & THERAPY
Volume 15, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13195-023-01176-y

Keywords

Frontotemporal lobar degeneration; Semantic variant primary progressive aphasia; MAPT gene; P301L mutation; Next-generation sequencing

Ask authors/readers for more resources

This study presents a large svPPA-affected family with the MAPT P301L mutation, providing insights into the underlying pathology and pathophysiological processes in svPPA caused by tauopathies.
BackgroundSemantic variant primary progressive aphasia (svPPA) is generally sporadic, with very few reports of tau pathology caused by MAPT mutations.MethodsA 64-year-old man was diagnosed with svPPA with MAPT P301L mutation. Clinical information, cognitive and language functions, multimodal magnetic resonance imaging (MRI), blood biomarkers, fluorodeoxyglucose (FDG) imaging and tau positron emission tomography (PET) were obtained.ResultsSemantic memory impairment was the earliest and most prominent symptom in this family. Tau accumulation and hypometabolism were observed prior to brain atrophy in mutation carriers. Plasma NfL and GFAP concentrations were elevated in the two svPPA patients. Some relative decreases and some relative increases in regional cerebral blood flow (CBF) as measured by arterial spin labelling (ASL) were observed in mutation carriers compared to noncarriers.ConclusionsThis study describes a large svPPA-affected family with the MAPT P301L mutation and provides an ideal model for inferring underlying pathology and pathophysiological processes in svPPA caused by tauopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available